These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29444138)

  • 1. Voxel level quantification of [11C]CURB, a radioligand for Fatty Acid Amide Hydrolase, using high resolution positron emission tomography.
    Rusjan PM; Knezevic D; Boileau I; Tong J; Mizrahi R; Wilson AA; Houle S
    PLoS One; 2018; 13(2):e0192410. PubMed ID: 29444138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic modelling using basis functions derived from two-tissue compartmental models with a plasma input function: general principle and application to [18F]fluorodeoxyglucose positron emission tomography.
    Hong YT; Fryer TD
    Neuroimage; 2010 May; 51(1):164-72. PubMed ID: 20156574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric mapping of [18F]fluoromisonidazole positron emission tomography using basis functions.
    Hong YT; Beech JS; Smith R; Baron JC; Fryer TD
    J Cereb Blood Flow Metab; 2011 Feb; 31(2):648-57. PubMed ID: 20736963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB.
    Boileau I; Rusjan PM; Williams B; Mansouri E; Mizrahi R; De Luca V; Johnson DS; Wilson AA; Houle S; Kish SJ; Tong J
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1827-35. PubMed ID: 26082009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.
    Wilson AA; Garcia A; Parkes J; Houle S; Tong J; Vasdev N
    Nucl Med Biol; 2011 Feb; 38(2):247-53. PubMed ID: 21315280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase.
    Boileau I; Bloomfield PM; Rusjan P; Mizrahi R; Mufti A; Vitcu I; Kish SJ; Houle S; Wilson AA; Tong J
    J Nucl Med; 2014 Dec; 55(12):1993-7. PubMed ID: 25413137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain using Positron Emission Tomography Tracer [
    Yamasaki T; Ohya T; Mori W; Zhang Y; Wakizaka H; Nengaki N; Fujinaga M; Kikuchi T; Zhang MR
    J Pharmacol Exp Ther; 2020 Jun; 373(3):353-360. PubMed ID: 32241809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid amide hydrolase is lower in young cannabis users.
    Jacobson MR; Watts JJ; Da Silva T; Tyndale RF; Rusjan PM; Houle S; Wilson AA; Ross RA; Boileau I; Mizrahi R
    Addict Biol; 2021 Jan; 26(1):e12872. PubMed ID: 31960544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB.
    Boileau I; Tyndale RF; Williams B; Mansouri E; Westwood DJ; Le Foll B; Rusjan PM; Mizrahi R; De Luca V; Zhou Q; Wilson AA; Houle S; Kish SJ; Tong J
    J Cereb Blood Flow Metab; 2015 Aug; 35(8):1237-40. PubMed ID: 26036940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-derived and arterial blood sampled input functions for quantitative PET imaging of the angiotensin II subtype 1 receptor in the kidney.
    Feng T; Tsui BM; Li X; Vranesic M; Lodge MA; Gulaldi NC; Szabo Z
    Med Phys; 2015 Nov; 42(11):6736-44. PubMed ID: 26520763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping human brain fatty acid amide hydrolase activity with PET.
    Rusjan PM; Wilson AA; Mizrahi R; Boileau I; Chavez SE; Lobaugh NJ; Kish SJ; Houle S; Tong J
    J Cereb Blood Flow Metab; 2013 Mar; 33(3):407-14. PubMed ID: 23211960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [
    Boileau I; Mansouri E; Williams B; Le Foll B; Rusjan P; Mizrahi R; Tyndale RF; Huestis MA; Payer DE; Wilson AA; Houle S; Kish SJ; Tong J
    Biol Psychiatry; 2016 Nov; 80(9):691-701. PubMed ID: 27345297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of monoamine oxidase-A in the human brain with [11C]befloxatone: quantification strategies and correlation with mRNA transcription maps.
    Zanotti-Fregonara P; Leroy C; Rizzo G; Roumenov D; Trichard C; Martinot JL; Bottlaender M
    Nucl Med Commun; 2014 Dec; 35(12):1254-61. PubMed ID: 25185897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parametric Net Influx Rate Images of
    Ilan E; Sandström M; Velikyan I; Sundin A; Eriksson B; Lubberink M
    J Nucl Med; 2017 May; 58(5):744-749. PubMed ID: 27789716
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategy for the formation of parametric images under conditions of low injected radioactivity applied to PET studies with the irreversible monoamine oxidase A tracers [11C]clorgyline and deuterium-substituted [11C]clorgyline.
    Logan J; Fowler JS; Ding YS; Franceschi D; Wang GJ; Volkow ND; Felder C; Alexoff D
    J Cereb Blood Flow Metab; 2002 Nov; 22(11):1367-76. PubMed ID: 12439294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
    Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
    Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Scale hierarchical generation of PET parametric maps: application and testing on a [11C]DPN study.
    Rizzo G; Turkheimer FE; Keihaninejad S; Bose SK; Hammers A; Bertoldo A
    Neuroimage; 2012 Feb; 59(3):2485-93. PubMed ID: 21924366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[(11)C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase.
    Shimoda Y; Fujinaga M; Hatori A; Yui J; Zhang Y; Nengaki N; Kurihara Y; Yamasaki T; Xie L; Kumata K; Ishii H; Zhang MR
    Bioorg Med Chem; 2016 Feb; 24(4):627-34. PubMed ID: 26740152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HRRT and HR+ scanners for quantitative (R)-[11C]verapamil, [11C]raclopride and [11C]flumazenil brain studies.
    van Velden FH; Mansor SM; van Assema DM; van Berckel BN; Froklage FE; Wang S; Schuit RC; Asselin MC; Lammertsma AA; Boellaard R; Huisman MC
    Mol Imaging Biol; 2015 Feb; 17(1):129-39. PubMed ID: 25028091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.